Indirect evidence suggests accelerated degradation of endothelium-derived nitric oxide (EDNO) by superoxide anion (°2) in hypercholesterolemic vessels (HV). To directly measure 0 2 production by normal vessels (NV) and HV, we used an assay for 02 based on the chemiluminescence (CL) of lucigenin (L). HV (1 mo cholesterol-fed rabbits) produced threefold more 02 than NV (1.47±0.20 nM/mg tissue/min, n = 7 vs. 0.52±0.05 nmol/mg tissue/min, n = 8, P < 0.001). Endothelial removal increased°2 production in NV (0.73±0.08, n = 6, P < 0.05), while decreasing it in HV (0.76±0.15, n = 5, P < 0.05). There was no difference between denuded HV and denuded NV. Oxypurinol, a noncompetitive inhibitor ofxanthine oxidase, normalized 02 production in HV, but had no effect in NV. In separate isometric tension studies treatment with oxypurinol improved acetylcholine induced relaxations in HV, while having no effect on responses in normal vessels. Oxypurinol did not alter relaxations to nitroprusside. Thus, the endothelium is a source of 02 in hypercholesterolemia probably via xanthine oxidase activation. Increased endothelial°2 production in HV may inactivate endothelium-derived nitric oxide and provide a source for other oxygen radicals, contributing to the early atherosclerotic process. (J. Clin. Invest. 1993.91:2546-2551
Introduction
Numerous disease processes, including hypercholesterolemia ( 1 ), atherosclerosis (2) , ischemia and reperfusion (3) , acute or chronic hypertension (4, 5) , congestive heart failure (6), and diabetes (7) , are associated with abnormal endothelium-dependent vascular relaxations. The endothelium-derived vascular relaxing factor (EDRF) l (8) , which is now recognized to be either nitric oxide (NO) (9) or a related compound (10) , is rapidly destroyed by superoxide radical generating systems such as xanthine/xanthine oxidase ( 11 ) or autooxidation of pyrogallol (12) , and is protected by superoxide dismutase (SOD) ( 13) . cholesterolemic and atherosclerotic rabbit aorta is markedly enhanced rather than impaired (14) . These findings indicate that the enzyme responsible for production of NO is not impaired by hypercholesterolemia and that there is not a deficiency of substrate or cofactors necessary for NO production. Recently, we also found that the release of biologically active EDRF can be markedly impaired by inhibition of endothelial SOD activity in normal vessels ( 15) , and that treatment with polyethylene-glycolated superoxide dismutase can partially restore impaired endothelium-dependent relaxation of atherosclerotic arteries ( 16) . These data strongly suggest that there is an excess generation ofsuperoxide anion within atherosclerotic vessels. This increased release of superoxide anion may result in accelerated degradation of either nitric oxide or a related component to an inactive form (either NO to NO-or R-NO to R-and NO-).
To test the hypothesis that superoxide anion release is increased by hypercholesterolemia, we used an assay for°2 production from normal vessels and vessels from cholesterol-fed animals based on the chemiluminescence oflucigenin. In additional experiments, we examined the potential role ofxanthine oxidase as a source of°2 in vessels of hypercholesterolemic animals.
Methods
Cholesterolfeeding. Male New Zealand white rabbits were randomly assigned to treatment and control groups. Hypercholesterolemia was induced by feeding a 1% cholesterol diet for 4-6 wk (n = 17). Agematched controls (n = 23) were maintained on standard rabbit chow.
Detection ofchemiluminescence in a cell-free°2 generating system. Chemiluminescence of lucigenin (bis-N-methylacridinium nitrate) was detected using a scintillation counter (LS 7000; Beckman Instruments, Inc., Fullerton, CA) in out-of-coincidence mode with a single active photomultiplier tube ( 17, 18) . The chemical specificity of this light yielding reaction for superoxide anion has been reported previously ( 19) , and in this study sensitivity and specificity ofthis assay was determined with xanthine ( 100-400 nM) and xanthine oxidase (0.002 U) to generate°-with or without SOD. To assay for 0-, lucigenin (0.25 mM), and xanthine with or without SOD (0.5 U/ml) was dissolved in a final volume of 2 ml Krebs-Hepes buffer (mM content; NaCl, 99.01; KCl, 4.69; CaC12, 1.87; MgSO4, 1.20; K2HPO4, 1.03; NaHCO3, 25.0; Na-Hepes, 20.0 and glucose, 1 1.1; initially gassed with 95% 02 and 5% CO2, pH 7.4). This assay solution was placed in glass scintillation vials and counted. Counts were then obtained at 2-min intervals after introduction of xanthine oxidase, and were corrected for background (counts obtained before adding xanthine oxidase).
Combinations of xanthine 50-400 nM and xanthine oxidase 0.002 U produced transient chemiluminescence signals in a manner dependent on the concentration of xanthine, which were abolished by SOD 0.5 U/ml (Fig. 1 A) .
Determination of°2 yieldfrom xanthine/xanthine oxidase reac- Fig. 1 A. There was an excellent correlation between chemiluminescence and superoxide anion generated with a simple fit (r = 0.99) (Fig. I B) .
Detection ofchemiluminescence elicited by normal and hypercholesterolemic vessels. On the day of the study, rabbits were killed by an overdose injection ofpentobarbital. The descending thoracic aorta was isolated and removed, taking care not to damage the endothelium. 5-mm ring segments ofthoracic aorta, dissected free ofadventitia, were incubated with Krebs-Hepes buffer maintained at 370C for 30 Lucigenin-mediated chemiluminescence with aortic rings was also measured in the presence of SOD (6 MM), catalase (0.2 MM), or after 30 min preincubation with mannitol (10 mM) to evaluate the specificity of this reaction.
To assess endothelial°2 production, endothelial removal was performed by gently rubbing the vessels intimal surface with the closed tips of hemostatic forceps.
O2 production ofnormal and hypercholesterolemic vessels with endothelium preincubated with or without oxypurinol. To examine the potential role of xanthine oxidase as a source of°2 in hypercholesterolemic vessels, we performed an additional series of studies. To perform these experiments, five additional control and five additional cholesterol-fed rabbits were studied. Both normal and hypercholesterolemic vessels were exposed to oxypurinol (1 mM), a noncompetitive antagonist of xanthine oxidase (22) for 30 min before study. The rings were then washed twice in buffer and then added to scintillation vials containing the lucigenin and buffer as described above.
To determine if oxypurinol could directly scavenge superoxide anions, we examined its effect on the lucigenin-mediated chemiluminescence produced by pyrogallol. Lucigenin-mediated chemiluminescence produced by 10 uM pyrogallol was assayed in the presence or absence of I mM oxypurinol. Chemiluminescence was measured 15 min after exposure to lucigenin as described above. Isometric tension studies. We also performed additional experiments to determine if°2 produced by xanthine oxidase in the hypercholesterolemic endothelium might impair endothelium-dependent vascular relaxation. Additional normal (n = 5), and cholesterol-fed (n = 5) rabbits were studied. Immediately before death, heparin sulfate (1,000 U) was administered intravenously to prevent blood coagulation. Eight 5- 
Results
Plasma cholesterol levels. The plasma cholesterol levels were 57±7 and 1,270±180 mg/dl for the control and cholesterol fed groups, respectively. 0°generation in normal and hypercholesterolemic vessels with or without endothelium. The chemiluminescence produced by lucigenin was assumed to be dependent on both extracellular and intracellular 0£ (17, 23) and increased with time as the lucigenin reached equilibrium with the intracellular space. In normal vessels a plateau of chemiluminescence was attained within 15 min (Fig. 2) . Lucigenin-mediated chemiluminescence ofaortic rings was also measured in the presence of 6 ,M superoxide dismutase, 0.2 ,M catalase, or after 30 min preincubation with mannitol 10 mM. The signals were reduced 7 1% by SOD (n = 5, P < 0.05), but not affected by catalase (n = 5) or mannitol (n = 5).
0£ production, estimated by measuring chemiluminescence 15 min after exposure to lucigenin, was 0.52±0.05 nmol/ mg tissue (dry wt) per min in normal vessels and was approximately threefold higher in hypercholesterolemic vessels (Fig.  3) . Endothelial removal increased 0£ production in normal vessels (NV) (Fig. 3) . In striking contrast, endothelial removal markedly decreased 0£ production in hypercholesterolemic vessels (HV) (Fig. 3) . Importantly, 0£ production by normal and hypercholesterolemic vessels without endothelium was similar.
Effects of oxypurinol on 0°generation in normal and hypercholesterolemic vessels. In hypercholesterolemic vessels, 1 mM oxypurinol markedly reduced 0£ production to a value similar to that observed in normal vessels (Fig. 4 A) . Importantly, oxypurinol had no effect on 0£ production in normal vessels. The effect of oxypurinol on the production of 02 was°2 The data are expressed as mean±SEM *P < 0.05 for NV with and without endothelium (paired t test); **P < 0.001 for HV vs. NV with endothelium (unpaired t test). tp < 0.05 for HV with vs. without endothelium (paired t test).
not related to direct scavenging of the 0£, because oxypurinol did not affect the lucigenin-mediated chemiluminescence produced by autooxidation of pyrogallol (Fig. 4 B) .
Effects ofoxypurinol on vascular responses in normal and hypercholesterolemic vessels. As shown in Fig. 5 A, endothelium-dependent relaxation in response to acetylcholine were markedly impaired in hypercholesterolemic vessels as compared with normal vessels. Oxypurinol did not effect relaxations of normal vessels to acetylcholine. In contrast, in hypercholesterolemic vessels oxypurinol markedly improved relaxations to acetylcholine. Importantly, as shown in Fig. 5 Figure 2 . Time course of 0°production estimated by lucigenin chemiluminescence in NV and HV vessels with intact endothelium. Data are expressed as mean±SEM ofeight normal and seven hypercholesterolemic rabbits. Paired measurements were made under identical conditions on two ring segments and averaged for each animal.
Discussion
The present study demonstrates that there is an excess generation of 0£ within hypercholesterolemic vessels, and that the source of0£ is not the smooth muscle layer but the endothelial cell itself or perhaps monocyte-macrophages (24) closely associated with the endothelium. Interestingly, the endothelium in normal vessels seems to have a protective effect, reducing vascular production of 0-. These findings may explain previous observations regarding the production of nitrogen oxides (NO and one-electron oxidation products of NO, including NO-) by the endothelium of atherosclerotic rabbits. In our previous study, release of nitrogen oxides, measured by chemiluminescence in the effluent ofperfused aortae from hypercholesterolemic and atherosclerotic rabbits, was paradoxically increased ( 14) . The vasorelaxant activity of these nitrogen oxides was markedly depressed, suggesting that they were being released as NO£. Furthermore these findings suggest excess generation of°2 could be responsible for augmented inactivation of EDRF, resulting in impaired endothelium-dependent relaxation in atherosclerotic arteries. The present experiments provide evidence that this hypothesis is correct.
In the endothelium, numerous sources of°-exist, including prostaglandin metabolism (25) , cytochrome p450 (26), electron transport (27) , and a process stimulated by protein kinase C (28) . Importantly, the endothelium contains xanthine dehydrogenase, which, under a variety of circumstances, can undergo a reversible conversion to xanthine oxidase (29) . The mechanisms responsible for conversion of xanthine dehydrogenase to xanthine oxidase are numerous and not completely understood, but include ischemia followed by reperfusion (30) , and inflammatory processes mediated by complement CSa or cytokines (31) strongly suggest that activation of xanthine oxidase occurs as a result ofchronic exposure to hypercholesterolemia. The mechanisms responsible for increased activity of xanthine oxidase in this setting remain unclear.
The present data also indicate that not only is excess xanthine oxidase production responsible for increasing°2 production by the endothelium of hypercholesterolemic vessels, but that the excess°2 may be responsible for altering endothelium-dependent vascular relaxations. Further, these studies may provide insight into why responses to exogenous nitrovasodilators are often normal when endothelium-dependent vascular relaxation are impaired in hypercholesterolemia. Exogenous nitrovasodilators such as nitroglycerin and sodium nitroprusside most likely release nitric oxide within or in close proximity to the vascular smooth muscle, at a site somewhat removed from the endothelial source of superoxide anions. (19) . Lucigenin chemiluminescence is produced by nanomolar concentrations of superoxide anion, but is insensitive to hydroxyl radical and hydrogen peroxide. In preliminary experiments, we examined the possibility that NO or related compounds could stimulate lucigenin chemiluminescence. The signal obtained from normal vessels was decreased, rather than increased by 3-1AM solutions of sodium nitroprusside (n = 3), and endothelial removal increased, rather than decreased chemiluminescence in normal vessels (Fig. 4) . In addition, I-,gM solutions of Angeli's salt (sodium trioxodinitrate), which spontaneously yield nitroxyl anion (32) , failed to cause lucigenin chemiluminescence.
Superoxide anion release can also be assessed using a variety of the methods, including spin-trapping techniques (33), luminol chemiluminescence (34) , and the reduction of cytochrome c (35, 36) . Spin-trapping techniques do not readily lend themselves to the study of intact vessels. The chemiluminescence of luminol is highly sensitive, but is not as specific for superoxide anion as lucigenin ( 19) . Finally, the reduction of cytochrome c is quite specific for the superoxide anion, but in preliminary experiments we found it to be less sensitive than the lucigenin technique. In the present experiments, we found lucigenin chemiluminescence to be highly quantitative with regard to superoxide anion production in cell free systems, and to be suitably sensitive for use with intact vessels. A potential criticism of the present work is that the lucigenin chemiluminescence produced by intact vessels was only 71% inhibited by extracellularly applied SOD. The precise explanation for this remains unclear, but likely relates to the fact that lucigenin produces chemiluminescence based on both intracellular and extracellular superoxide anion production. Because of this, lucigenin chemiluminescence produced by intact vessels or tissue is not completely inhibited by extracellularly applied SOD. Such a phenomenon has been observed in zymosan-activated neutrophils (23) and bovine pulmonary arteries ( 17) .
O-has been implicated in the oxidation of LDL (37) . It is interesting to speculate that increased production of°2-by the endothelium in hypercholesterolemia may further enhance LDL modification and thus lipid accumulation within the vascular wall.°2-also provides a source of other oxygen-centered radicals, such as H202 and OH, which may participate in lipid peroxidation and serve to damage cellular membranes (38) . In addition, the O2 may react with NO, which is also produced in excess within the endothelium of hypercholesterolemic animals to produce the highly injurious peroxynitrite radical (39) .
In these respects, the increase in O2 production in the setting of hypercholesterolemia may not only inactivate endotheliumderived nitric oxide, but may also serve as an early event in the atherosclerotic process.
